Undark Magazine

Why the FDA Is Embracing Old Math for New Drugs

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Applied Clinical Trials Online

How Bayesian Approaches Can Revolutionize Rare Disease Clinical Trials

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Medscape

FDA Changes Drug Trial Guidance: Experts Take Sides

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
AOL

How To Speed Up the Search for Cures Through a Change in Probability Theory

Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...
JD Supra

Frequentist or Bayesian? All Roads Lead to Smarter Trials with FDA’s New Bayesian Guidance

Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
IEEE

A New Versatile Discrete Distribution for Censored Data: Frequentist and Bayesian Methods With Real-Life Applications

This study introduces a novel and highly flexible class of discrete probability distributions tailored to model the diverse monotonic failure-rate patterns frequently observed in stock-market data.